Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis
Open Access
- 23 June 2017
- journal article
- research article
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 2 (1) , 17022
Abstract
Brown adipose tissue dissipates energy in the form of heat. Recent studies have shown that adult humans possess both classical brown and beige adipocytes (brown-like adipocytes in white adipose tissue, WAT), and stimulating brown and beige adipocyte formation can be a new avenue to treat obesity. Angiotensin II (AngII) is a peptide hormone that plays important roles in energy metabolism via its angiotensin type 1 or type 2 receptors (AT1R and AT2R). Adipose tissue is a major source of AngII and expresses both types of its receptors, implying the autocrine and paracrine role of AngII in regulating adipose functions and self-remodeling. Here, based on the in vitro studies on primary cultures of mouse white adipocytes, we report that, AT2R activation, either by AngII or AT2R agonist (C21), induces white adipocyte browning, by increasing PPARγ expression, at least in part, via ERK1/2, PI3kinase/Akt and AMPK signaling pathways. It is also found that AngII–AT2R enhances brown adipogenesis. In the in vivo studies on mice, administration of AT1R antagonist (ZD7155) or AT2R agonist (C21) leads to the increase of WAT browning, body temperature and serum adiponectin, as well as the decrease of WAT mass and the serum levels of TNFα, triglycerides and free fatty acids. In addition, AT2R-induced browning effect is also observed in human white adipocytes, as evidenced by the increased UCP1 expression and oxygen consumption. Finally, we provide evidence that AT2R plays important roles in hormone T3-induced white adipose browning. This study, for the first time, reveals the browning and brown adipogenic effects of AT2R and suggests a potential therapeutic target to combat obesity and related metabolic disorders.Keywords
This publication has 66 references indexed in Scilit:
- Angiotensin II Signaling in Human Preadipose Cells: Participation of ERK1,2-Dependent Modulation of AktPLOS ONE, 2013
- Angiotensin AT2 Receptor Contributes towards Gender Bias in Weight GainPLOS ONE, 2013
- Human BAT Possesses Molecular Signatures That Resemble Beige/Brite CellsPLOS ONE, 2012
- Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ ActivationPLOS ONE, 2012
- Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db miceCardiovascular Diabetology, 2012
- PPARγ agonists Induce a White-to-Brown Fat Conversion through Stabilization of PRDM16 ProteinCell Metabolism, 2012
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Adipose tissue–specific dysregulation of angiotensinogen by oxidative stress in obesityMetabolism, 2010
- Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARγEuropean Journal of Pharmacology, 2006